89bio Initiates Phase 2b ENLIVEN Trial of BIO89-100 for the Treatment of NASH by Carolyn Helms | Jun 10, 2021 | Uncategorized
Inozyme Announces Acceptance of First European Clinical Trial Application for Phase 1/2 Clinical Trial of INZ-701 in ABCC6 Deficiency by Carolyn Helms | Jun 9, 2021 | Portfolio News
Inozyme Announces Acceptance of First European Clinical Trial Application for Phase 1/2 Clinical Trial of INZ-701 in ABCC6 Deficiency by Carolyn Helms | Jun 9, 2021 | Uncategorized
Neurana Pharmaceuticals Announces 50% Enrollment in Phase 3, RESUME-1 Study by Carolyn Helms | Jun 7, 2021 | Portfolio News
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome by Carolyn Helms | Jun 3, 2021 | Portfolio News
